Neuro-oncology Certification Examination Committee Contributors
Christian Grommes, MD, Chair, Memorial Sloan Kettering Cancer Center
Disclosures: Received consultant fees from Ono, BTG, and Roche.
Andrea Wasilewski, MD, Vice Chair, Givens Brain Tumor Center
Disclosures: Nothing to disclose.
David M. Cachia, MD, UMass Memorial Medical Center
Disclosures: Received consulting fees from Red Hill BioPharma Ltd., Dedham Group, Guidepoint Global LLC; Speaker fee from Massachusetts Neurological Society.
Yasmin Khakoo, MD, Memorial Sloan Kettering Cancer Center
Disclosures: Receive compensation as Editor-in-Chief of Pediatric Neurology; Nevus Outreach, Inc $10K annually.
Heather E. Leeper, MD, University of Chicago
Disclosures: Nothing to disclose.
Douglas E. Ney, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Nothing to disclose.
Lauren Schaff, MD, Memorial Sloan Kettering Cancer Center
Disclosures: Paid Ad hoc consultant to Guidepoint consulting company; BTG, plc - financial research support Merck - research support in the form of drug supply; Patent pending related to low-dose glucarpidase with methotrexate for treatment of CNS lymphoma.
Roy E. Strowd, III, MD, Wake Forest Baptist Health
Disclosures: Received medical consulting fees for Monteris Medical. Consulting lecturer for Kaplan and Lecturio and Springer Healthcare; Compensation for serving on the data safety monitoring board for study for schwannomatosis (NCT04163419); Editorial stipend from the AAN; Research support from Jazz pharmaceuticals.
Joon Uhm, MD, Mayo Clinic – Rochester
Disclosures: Speaker fee received from Zai Labs for educational (Zoom) sessions to review current standard of care brain tumor therapies.